Enterprise Value
$2.15 B
-$89.40 M-3.99%
4 min ago
Summary:
Protagonist Therapeutics enterprise value is currently $2.15 billion, with a fall of -$89.40 million (-3.99%) during the most recent trading day. Over the past year, it has increased by +$1.08 billion (+100.46%). PTGX enterprise value is now -23.21% below its all-time high of $2.80 billion.PTGX Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PTGX Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -4.0% | -3.8% | -3.8% |
| 1 m1 month | -10.0% | -9.5% | -9.5% |
| 3 m3 months | -14.8% | -14.1% | -14.2% |
| 6 m6 months | +24.0% | +9.2% | +7.7% |
| ytdytd | -1.4% | -1.4% | -1.4% |
| 1 y1 year | +100.5% | +80.4% | +74.7% |
| 5 y5 years | +1193.7% | +1146.1% | +469.1% |
PTGX Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $2.39 B | -10.0% | $2.15 B | at low |
| 3 m | 3 months | $2.80 B | -23.2% | $2.15 B | at low |
| 6 m | 6 months | $2.80 B | -23.2% | $1.65 B | +30.1% |
| 1 y | 1 year | $2.80 B | -23.2% | $1.07 B | +100.5% |
| 3 y | 3 years | $2.80 B | -23.2% | $214 M | +906.3% |
| 5 y | 5 years | $2.80 B | -23.2% | $126 M | +1600.4% |
| alltime | all time | $2.80 B | -23.2% | $57 M | +3641.1% |
Protagonist Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $2.15 B(-1.4%) |
| 2024 | $2.18 B(+91.6%) |
| 2023 | $1.14 B(+188.4%) |
| 2022 | $394.49 M(-74.0%) |
| 2021 | $1.52 B(+97.0%) |
| Date | Value |
|---|---|
| 2020 | $770.51 M(+338.1%) |
| 2019 | $175.89 M(+138.3%) |
| 2018 | $73.82 M(-77.8%) |
| 2017 | $332.61 M(-4.0%) |
| 2016 | $346.64 M |
FAQ
- What is Protagonist Therapeutics enterprise value?
- What is the all time high enterprise value for Protagonist Therapeutics?
- What is PTGX enterprise value year-to-date change?
- What is Protagonist Therapeutics enterprise value year-on-year change?
What is Protagonist Therapeutics enterprise value?
The current enterprise value of PTGX is $2.15 B
What is the all time high enterprise value for Protagonist Therapeutics?
Protagonist Therapeutics all-time high enterprise value is $2.80 B
What is PTGX enterprise value year-to-date change?
Protagonist Therapeutics enterprise value has changed by -$31.59 M (-1.45%) since the beginning of the year
What is Protagonist Therapeutics enterprise value year-on-year change?
Over the past year, PTGX enterprise value has changed by +$1.08 B (+100.46%)